{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:10:52Z","timestamp":1790619052243,"version":"4.1.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100024835","name":"Australasian and New Zealand Society of Paediatric Endocrinology and Diabetes","doi-asserted-by":"publisher","award":["research grant No. 2019"],"award-info":[{"award-number":["research grant No. 2019"]}],"id":[{"id":"10.13039\/501100024835","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australasian Society for Inborn Errors of Metabolism","award":["2020"],"award-info":[{"award-number":["2020"]}]},{"name":"LabPlus, Auckland City Hospital Research","award":["2020"],"award-info":[{"award-number":["2020"]}]},{"name":"LabPlus, Auckland City Hospital Research","award":["2023"],"award-info":[{"award-number":["2023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Simultaneous measurement of multiple steroids in dried bloodspots facilitates accurate newborn screening (NBS) for classic congenital adrenal hyperplasia (CAH), although false-positive (FP) tests are encountered. Some babies with milder forms of CAH, who may benefit from early detection and treatment, can be missed by screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This work aims to evaluate a method for expanded steroid profiling in NBS bloodspots to identify novel sensitive and specific markers that will inform improvements for screening for CAH, and to identify the metabolic routes to excessive androgen synthesis in CAH in the newborn period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A method to measure 41 steroids by liquid chromatography\u2013tandem mass spectrometry is described and evaluated using manufactured bloodspots and residual NBS specimens from 43 babies with true-positive (TP), 11 babies with false-negative (FN), and 389 babies with false-positive (FP) screening results. Mann-Whitney analysis was used to determine if steroid measurements could distinguish between samples from babies with CAH and FP specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The method was sufficiently precise and accurate for all steroids but was less sensitive for steroids of the mineralocorticoid pathway. Seven novel 11-oxygenated steroid markers were higher in TP and FN samples when compared to the FP group and were the most informative for screening. The most sensitive and specific marker, 21-deoxycortisone, was elevated in 52 of 53 CAH cases and was not detected in any FP specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The 11-oxygenated steroids are the most sensitive markers in dried bloodspots in the newborn period. Steroid profiling suggests that androgen excess in CAH in the newborn period is via several interconnected metabolic routes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf402","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:08:21Z","timestamp":1752502101000},"page":"e462-e475","source":"Crossref","is-referenced-by-count":4,"title":["Expanded Steroid Profiling Identifies Novel Newborn Screening Markers for Congenital Adrenal Hyperplasia"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5142-4239","authenticated-orcid":false,"given":"Mark R","family":"de Hora","sequence":"first","affiliation":[{"name":"Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital , Auckland 1040 ,","place":["New Zealand"]},{"name":"Liggins Institute, University of Auckland , Auckland 1010 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thorstensen","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland , Auckland 1010 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-3279","authenticated-orcid":false,"given":"Natasha L","family":"Heather","sequence":"additional","affiliation":[{"name":"Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital , Auckland 1040 ,","place":["New Zealand"]},{"name":"Liggins Institute, University of Auckland , Auckland 1010 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-3473","authenticated-orcid":false,"given":"Benjamin","family":"Albert","sequence":"additional","affiliation":[{"name":"Liggins Institute, University of Auckland , Auckland 1010 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-0626","authenticated-orcid":false,"given":"Dianne","family":"Webster","sequence":"additional","affiliation":[{"name":"Newborn Screening, Specialist Chemical Pathology, LabPlus, Auckland City Hospital , Auckland 1040 ,","place":["New Zealand"]},{"name":"Liggins Institute, University of Auckland , Auckland 1010 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2187-8811","authenticated-orcid":false,"given":"Paul L","family":"Hofman","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Liggins Institute, University of Auckland , Auckland 1010 ,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"1","key":"2026012101521388200_dgaf402-B1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"issue":"4","key":"2026012101521388200_dgaf402-B2","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2026012101521388200_dgaf402-B3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/ijns6010006","article-title":"Measurement of 17-hydroxyprogesterone by LCMSMS improves newborn screening for CAH due to 21-hydroxylase deficiency in New Zealand","volume":"6","author":"de Hora","year":"2020","journal-title":"Int J Neonat Screen"},{"issue":"4","key":"2026012101521388200_dgaf402-B4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/ijns9040058","article-title":"Best practice for identification of classical 21-hydroxylase deficiency should include 21 deoxycortisol analysis with appropriate isomeric steroid separation","volume":"9","author":"Greaves","year":"2023","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"2026012101521388200_dgaf402-B5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/ijns6030063","article-title":"Evaluation of a two-tier screening pathway for congenital adrenal hyperplasia in the New South Wales newborn screening programme","volume":"6","author":"Lai","year":"2020","journal-title":"Int J Neonatal Screen"},{"issue":"11","key":"2026012101521388200_dgaf402-B6","doi-asserted-by":"crossref","first-page":"e4487","DOI":"10.1210\/clinem\/dgab464","article-title":"Second-tier testing for 21-hydroxylase deficiency in The Netherlands: a newborn screening pilot study","volume":"106","author":"Stroek","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026012101521388200_dgaf402-B7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4155\/bio.16.6","article-title":"Determination of a steroid profile in heel prick blood using LC-MS\/MS","volume":"8","author":"Boelen","year":"2016","journal-title":"Bioanalysis"},{"issue":"6","key":"2026012101521388200_dgaf402-B8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3343\/alm.2015.35.6.578","article-title":"Dried blood spot testing for seven steroids using liquid chromatography-tandem mass spectrometry with reference interval determination in the Korean population","volume":"35","author":"Kim","year":"2015","journal-title":"Ann Lab Med"},{"key":"2026012101521388200_dgaf402-B9","doi-asserted-by":"crossref","first-page":"109056","DOI":"10.1016\/j.steroids.2022.109056","article-title":"Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: application to newborn screening for congenital adrenal hyperplasia in China","volume":"185","author":"Zhan","year":"2022","journal-title":"Steroids"},{"issue":"5","key":"2026012101521388200_dgaf402-B10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026012101521388200_dgaf402-B11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mce.2016.08.014","article-title":"A new Dawn for androgens: novel lessons from 11-oxygenated C19 steroids","volume":"441","author":"Pretorius","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"2026012101521388200_dgaf402-B12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"2026012101521388200_dgaf402-B13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsbmb.2017.07.034","article-title":"Adrenal C11-oxy C21 steroids contribute to the C11-oxy C19 steroid pool via the backdoor pathway in the biosynthesis and metabolism of 21-deoxycortisol and 21-deoxycortisone","volume":"174","author":"Barnard","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026012101521388200_dgaf402-B14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jsbmb.2017.12.014","article-title":"The in vitro metabolism of 11beta-hydroxyprogesterone and 11-ketoprogesterone to 11-ketodihydrotestosterone in the backdoor pathway","volume":"178","author":"van Rooyen","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"24","key":"2026012101521388200_dgaf402-B15","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1080\/14767058.2019.1598362","article-title":"Altered umbilical sex steroids in preterm infants born small for gestational age","volume":"33","author":"Allvin","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"2026012101521388200_dgaf402-B16","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1373\/clinchem.2016.263434","article-title":"Dried blood spot reference intervals for steroids and amino acids in a neonatal cohort of the national Children's study","volume":"62","author":"Dietzen","year":"2016","journal-title":"Clin Chem"},{"key":"2026012101521388200_dgaf402-B17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cca.2017.05.002","article-title":"Reference intervals for plasma concentrations of adrenal steroids measured by LC-MS\/MS: impact of gender, age, oral contraceptives, body mass index and blood pressure status","volume":"470","author":"Eisenhofer","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2026012101521388200_dgaf402-B18","first-page":"186","article-title":"A liquid chromatography\/tandem mass spectometry profile of 16 Serum steroids, including 21-deoxycortisol and 21-deoxycorticosterone, for management of congenital adrenal hyperplasia","volume":"1","author":"Fiet","year":"2017","journal-title":"J Endocr Soc"},{"key":"2026012101521388200_dgaf402-B19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jpba.2018.11.035","article-title":"Simultaneous analysis by LC-MS\/MS of 22 ketosteroids with hydroxylamine derivatization and underivatized estradiol from human plasma, serum and prostate tissue","volume":"164","author":"Hakkinen","year":"2019","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"2026012101521388200_dgaf402-B20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000346406","article-title":"Implementation of a liquid chromatography tandem mass spectrometry assay for eight adrenal C-21 steroids and pediatric reference data","volume":"79","author":"Kulle","year":"2013","journal-title":"Horm Res Paediatr"},{"issue":"7-8","key":"2026012101521388200_dgaf402-B21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.clinbiochem.2013.01.002","article-title":"A sensitive and rapid mass spectrometric method for the simultaneous measurement of eight steroid hormones and CALIPER pediatric reference intervals","volume":"46","author":"Kyriakopoulou","year":"2013","journal-title":"Clin Biochem"},{"issue":"3","key":"2026012101521388200_dgaf402-B22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2012-2912","article-title":"Liquid chromatography-tandem mass spectrometry analysis of human adrenal vein 19-carbon steroids before and after ACTH stimulation","volume":"98","author":"Rege","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026012101521388200_dgaf402-B23","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1210\/jc.2015-1023","article-title":"Profiles of 21-carbon steroids in 21-hydroxylase deficiency","volume":"100","author":"Turcu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026012101521388200_dgaf402-B24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3343\/alm.2019.39.3.263","article-title":"Dried blood spot multiplexed steroid profiling using liquid chromatography tandem mass spectrometry in Korean neonates","volume":"39","author":"Choi","year":"2019","journal-title":"Ann Lab Med"},{"key":"2026012101521388200_dgaf402-B25","author":"de Hora"},{"issue":"4","key":"2026012101521388200_dgaf402-B26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/ijns8040056","article-title":"Evaluation of a new laboratory protocol for newborn screening for congenital adrenal hyperplasia in New Zealand","volume":"8","author":"de Hora","year":"2022","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"2026012101521388200_dgaf402-B27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13659-019-0204-3","article-title":"Quantitative-profiling method of Serum steroid hormones by hydroxylamine-derivatization HPLC-MS","volume":"9","author":"Liu","year":"2019","journal-title":"Nat Prod Bioprospect"},{"issue":"19","key":"2026012101521388200_dgaf402-B28","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1002\/rcm.3205","article-title":"Analysis of testosterone and dihydrotestosterone from biological fluids as the oxime derivatives using high-performance liquid chromatography\/tandem mass spectrometry","volume":"21","author":"Kalhorn","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"5","key":"2026012101521388200_dgaf402-B29","doi-asserted-by":"crossref","first-page":"e0233724","DOI":"10.1371\/journal.pone.0233724","article-title":"Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia","volume":"15","author":"Grecso","year":"2020","journal-title":"PLoS One"},{"key":"2026012101521388200_dgaf402-B30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2021.10.063","article-title":"21-Deoxycortisol is a key screening marker for 21-hydroxylase deficiency","volume":"242","author":"Held","year":"2022","journal-title":"J Pediatr"},{"issue":"3","key":"2026012101521388200_dgaf402-B31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/ijns5030033","article-title":"Wisconsin's screening algorithm for the identification of newborns with congenital adrenal hyperplasia","volume":"5","author":"Bialk","year":"2019","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"2026012101521388200_dgaf402-B32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1210\/clinem\/dgab793","article-title":"Maternal 11-ketoandrostenedione rises through normal pregnancy and is the dominant 11-oxygenated androgen in cord blood","volume":"107","author":"He","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026012101521388200_dgaf402-B33","doi-asserted-by":"crossref","first-page":"105724","DOI":"10.1016\/j.jsbmb.2020.105724","article-title":"The A-ring reduction of 11-ketotestosterone is efficiently catalysed by AKR1D1 and SRD5A2 but not SRD5A1","volume":"202","author":"Barnard","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"2026012101521388200_dgaf402-B34","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/clinchem\/38.9.1830","article-title":"Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays","volume":"38","author":"Wong","year":"1992","journal-title":"Clin Chem"},{"issue":"5","key":"2026012101521388200_dgaf402-B35","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000314970","article-title":"Serum concentrations of adrenal steroids and their precursors as a measure of maturity of adrenocortical function in very premature newborns","volume":"74","author":"Nykanen","year":"2010","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"2026012101521388200_dgaf402-B36","first-page":"20","article-title":"Skin care guidelines for skin care guidelines for infants aged 23-30 weeks\u2019 gestation: a review of the literature","volume":"14","author":"Allwood","year":"2011","journal-title":"Neonat Paediatr Child Health Nurs"},{"issue":"11","key":"2026012101521388200_dgaf402-B37","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026012101521388200_dgaf402-B38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1515\/jpem-2016-0203","article-title":"Monitoring steroid replacement therapy in children with congenital adrenal hyperplasia","volume":"30","author":"Birkebaek","year":"2017","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"2026012101521388200_dgaf402-B39","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1373\/clinchem.2010.146035","article-title":"Monitoring of therapy in congenital adrenal hyperplasia","volume":"56","author":"Dauber","year":"2010","journal-title":"Clin Chem"},{"issue":"1","key":"2026012101521388200_dgaf402-B40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000315910","article-title":"Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia","volume":"75","author":"Sarafoglou","year":"2011","journal-title":"Horm Res Paediatr"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf402\/63753772\/dgaf402.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/e462\/63753772\/dgaf402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/2\/e462\/63753772\/dgaf402.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:52:23Z","timestamp":1768978343000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/2\/e462\/8200955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,14]]},"published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf402","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,7,14]]}}}